Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis

Khalid Benkhadra, Fares Alahdab, Shrikant U. Tamhane, Rozalina McCoy, Larry J. Prokop, Mohammad H Murad

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The relative efficacy of continuous subcutaneous insulin infusion and multiple daily injections in individuals with type 1 diabetes is unclear. We sought to synthesize the existing evidence about the effect of continuous subcutaneous insulin infusion on glycosylated hemoglobin, hypoglycemic events, and time spent in hypoglycemia compared to multiple daily injections. We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and Database of Systematic Reviews, and Scopus from January 2008 through November 2015 for randomized controlled trials that enrolled children or adults with type 1 diabetes. Trials identified in a previous systematic review and published prior to 2008 were also included. We included 25 randomized controlled trials at moderate risk of bias. Meta-analysis showed a significant reduction in glycosylated hemoglobin in patients treated with continuous subcutaneous insulin infusion compared to multiple daily injections (mean difference 0.37; 95 % confidence interval, 0.24–0.51). This effect was demonstrated in both children and adults. There was no significant difference in minor or severe hypoglycemic events. Continuous subcutaneous insulin infusion was associated with lower incidence of nocturnal hypoglycemia. There was no significant difference in the time spent in hypoglycemia. In children and adults with type 1 diabetes and compared to multiple daily injections, continuous subcutaneous insulin infusion is associated with a modest reduction in glycosylated hemoglobin. There was no difference in severe or minor hypoglycemia, but likely a lower incidence of nocturnal hypoglycemia with continuous subcutaneous insulin infusion.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalEndocrine
DOIs
StateAccepted/In press - Aug 1 2016

Fingerprint

Subcutaneous Infusions
Type 1 Diabetes Mellitus
Meta-Analysis
Hypoglycemia
Insulin
Injections
Glycosylated Hemoglobin A
Hypoglycemic Agents
Randomized Controlled Trials
Incidence
MEDLINE
Databases
Confidence Intervals

Keywords

  • Continuous subcutaneous infusion
  • Diabetes
  • Diabetes mellitus type 1
  • Insulin
  • Multiple daily injections
  • Systematic review

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes : a systematic review and meta-analysis. / Benkhadra, Khalid; Alahdab, Fares; Tamhane, Shrikant U.; McCoy, Rozalina; Prokop, Larry J.; Murad, Mohammad H.

In: Endocrine, 01.08.2016, p. 1-8.

Research output: Contribution to journalArticle

@article{10adc03cd6f94474a91fc1ad61f3278e,
title = "Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis",
abstract = "The relative efficacy of continuous subcutaneous insulin infusion and multiple daily injections in individuals with type 1 diabetes is unclear. We sought to synthesize the existing evidence about the effect of continuous subcutaneous insulin infusion on glycosylated hemoglobin, hypoglycemic events, and time spent in hypoglycemia compared to multiple daily injections. We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and Database of Systematic Reviews, and Scopus from January 2008 through November 2015 for randomized controlled trials that enrolled children or adults with type 1 diabetes. Trials identified in a previous systematic review and published prior to 2008 were also included. We included 25 randomized controlled trials at moderate risk of bias. Meta-analysis showed a significant reduction in glycosylated hemoglobin in patients treated with continuous subcutaneous insulin infusion compared to multiple daily injections (mean difference 0.37; 95 {\%} confidence interval, 0.24–0.51). This effect was demonstrated in both children and adults. There was no significant difference in minor or severe hypoglycemic events. Continuous subcutaneous insulin infusion was associated with lower incidence of nocturnal hypoglycemia. There was no significant difference in the time spent in hypoglycemia. In children and adults with type 1 diabetes and compared to multiple daily injections, continuous subcutaneous insulin infusion is associated with a modest reduction in glycosylated hemoglobin. There was no difference in severe or minor hypoglycemia, but likely a lower incidence of nocturnal hypoglycemia with continuous subcutaneous insulin infusion.",
keywords = "Continuous subcutaneous infusion, Diabetes, Diabetes mellitus type 1, Insulin, Multiple daily injections, Systematic review",
author = "Khalid Benkhadra and Fares Alahdab and Tamhane, {Shrikant U.} and Rozalina McCoy and Prokop, {Larry J.} and Murad, {Mohammad H}",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s12020-016-1039-x",
language = "English (US)",
pages = "1--8",
journal = "Endocrine",
issn = "1355-008X",
publisher = "Humana Press",

}

TY - JOUR

T1 - Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes

T2 - a systematic review and meta-analysis

AU - Benkhadra, Khalid

AU - Alahdab, Fares

AU - Tamhane, Shrikant U.

AU - McCoy, Rozalina

AU - Prokop, Larry J.

AU - Murad, Mohammad H

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The relative efficacy of continuous subcutaneous insulin infusion and multiple daily injections in individuals with type 1 diabetes is unclear. We sought to synthesize the existing evidence about the effect of continuous subcutaneous insulin infusion on glycosylated hemoglobin, hypoglycemic events, and time spent in hypoglycemia compared to multiple daily injections. We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and Database of Systematic Reviews, and Scopus from January 2008 through November 2015 for randomized controlled trials that enrolled children or adults with type 1 diabetes. Trials identified in a previous systematic review and published prior to 2008 were also included. We included 25 randomized controlled trials at moderate risk of bias. Meta-analysis showed a significant reduction in glycosylated hemoglobin in patients treated with continuous subcutaneous insulin infusion compared to multiple daily injections (mean difference 0.37; 95 % confidence interval, 0.24–0.51). This effect was demonstrated in both children and adults. There was no significant difference in minor or severe hypoglycemic events. Continuous subcutaneous insulin infusion was associated with lower incidence of nocturnal hypoglycemia. There was no significant difference in the time spent in hypoglycemia. In children and adults with type 1 diabetes and compared to multiple daily injections, continuous subcutaneous insulin infusion is associated with a modest reduction in glycosylated hemoglobin. There was no difference in severe or minor hypoglycemia, but likely a lower incidence of nocturnal hypoglycemia with continuous subcutaneous insulin infusion.

AB - The relative efficacy of continuous subcutaneous insulin infusion and multiple daily injections in individuals with type 1 diabetes is unclear. We sought to synthesize the existing evidence about the effect of continuous subcutaneous insulin infusion on glycosylated hemoglobin, hypoglycemic events, and time spent in hypoglycemia compared to multiple daily injections. We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and Database of Systematic Reviews, and Scopus from January 2008 through November 2015 for randomized controlled trials that enrolled children or adults with type 1 diabetes. Trials identified in a previous systematic review and published prior to 2008 were also included. We included 25 randomized controlled trials at moderate risk of bias. Meta-analysis showed a significant reduction in glycosylated hemoglobin in patients treated with continuous subcutaneous insulin infusion compared to multiple daily injections (mean difference 0.37; 95 % confidence interval, 0.24–0.51). This effect was demonstrated in both children and adults. There was no significant difference in minor or severe hypoglycemic events. Continuous subcutaneous insulin infusion was associated with lower incidence of nocturnal hypoglycemia. There was no significant difference in the time spent in hypoglycemia. In children and adults with type 1 diabetes and compared to multiple daily injections, continuous subcutaneous insulin infusion is associated with a modest reduction in glycosylated hemoglobin. There was no difference in severe or minor hypoglycemia, but likely a lower incidence of nocturnal hypoglycemia with continuous subcutaneous insulin infusion.

KW - Continuous subcutaneous infusion

KW - Diabetes

KW - Diabetes mellitus type 1

KW - Insulin

KW - Multiple daily injections

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84982801599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982801599&partnerID=8YFLogxK

U2 - 10.1007/s12020-016-1039-x

DO - 10.1007/s12020-016-1039-x

M3 - Article

C2 - 27477293

AN - SCOPUS:84982801599

SP - 1

EP - 8

JO - Endocrine

JF - Endocrine

SN - 1355-008X

ER -